Low-density lipoproteins enhance transforming growth factor-beta 1 (TGF- β1) and monocyte chemotactic protein-1 (MCP-1) expression induced by cyclosporin in human mesangial cells

Clinical and Experimental Immunology

Volumn 117, Issue 2, 1999, Pages 355-360

  Di Paolo, S ^a   Grandaliano, G ^a   Gesualdo, L ^a   Ranieri, E ^a   Schena, F P ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Cyclosporin; Human mesangial cells; Low density lipoprotein; Monocyte chemotactic protein 1; Transforming growth factor beta 1

Indexed keywords

CYCLOSPORIN A; LOW DENSITY LIPOPROTEIN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CELL PROLIFERATION; DRUG EFFECT; GENE EXPRESSION; GLOMERULOSCLEROSIS; HUMAN; HUMAN CELL; HYPERLIPIDEMIA; IMMUNOSUPPRESSIVE TREATMENT; MACROPHAGE; MESANGIUM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION;

CELL DIVISION; CELLS, CULTURED; CHEMOKINE CCL2; CYCLOSPORINS; DRUG SYNERGISM; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLOMERULAR MESANGIUM; GROWTH INHIBITORS; HUMANS; LIPOPROTEINS, LDL; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 0032819310     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1999.00965.x     Document Type: Article

References (35)

1. 1 Bennett WM, DeMattos A, Meyer MM, Andoh T, Barry JM. Chronic cyclosporine nephropathy: the Achilles' heel of immunosuppressive therapy. Kidney Int 1996; 50:1089-100.
2. 2 Bertani T, Ferrazzi P, Schieppati A et al. Nature and extent of glomerular injury induced by cyclosporine in heart transplant patients. Kidney Int 1991; 40:243-50.
3. 3 Kopp JB, Klotman PE. Cellular and molecular mechanisms of cyclosporine nephrotoxicily. J Am Soc Nephrol 1990; 1:162-79.
4. 4 Wolf G, Killen PD, Neilson EG. Cyclosporin A stimulates transcription and procollagen secretion in tubulointerstitial fibroblasts and proximal tubular cells. J Am Soc Nephrol 1990; 1:918-22.
5. 5 Ghiggeri GM, Altieri P, Oleggini R et al. Cyclosporine enhances the synthesis of selected extracellular matrix proteins by renal cells 'in culture'. Transplantation 1994; 57:1382-8.
6. 6 Wolf G, Neilson EG. Increases in levels of collagen types I and IV messenger ribonucleic acid in murine kidneys after treatment with cyclosporin. Nephron 1992; 60:87-91.
7. 7 Wolf G, Thaiss F, Stahl RAK. Cyclosporine stimulates expression of transforming growth factor β in renal cells. Transplantation 1995; 60:237-41.
8. 8 Young BA, Burdmann EA, Johnson RJ et al. Cellular proliferation and macrophage influx precede interstitial fibrosis in cyclosporine nephrotoxicity. Kidney Int 1995; 48:439-48.
9. 9 Kasiske BL, Umen AJ. Persistent hyperlipidemia in renal transplant patients, Med 1987; 66:309-16.
10. 10 Appel G. Lipid abnormalities in renal disease. Kidney Int 1991; 39:169-83.
11. 11 Ordonez JD, Haitt RA, Killbrew EJ, Firman BH. The increased risk of coronary heart disease associated with nephrotic syndrome. Kidney Int 1993; 44:638-43.
12. 12 Grone H-J, Hohbach J, Grone EF. Modulation of glomerular sclerosis and interstitial fibrosis by native and modified lipoproteins. Kidney Int 1996; 49:(Suppl. 54):S18-S22.
13. 13 Van Goor H, Fidler V, Weening JJ, Grond J. Determinants of focal and segmental glomerulosclerosis in the rat after renal ablation. Lab Invest 1991; 64:754-65.
14. 14 Kasiske BL, O'Donnell MP, Schmitz PG, Kim Y, Keane WF. The renal injury of diet-induced hypercolesterolemia in rats. Kidney Int 1990; 37:880-91.
15. 15 Rovin BH, Yoshimura T, Tan L. Cytokine-induced production of monocyte chemoattractant protein-1 by cultured human mesangial cells. J Immunol 1992; 148:2148-53.
16. 16 Roberts AB. Sporn MB. Physiological actions and clinical applications of transforming growth factor β (TGF-β). Growth Factors 1993; 8:1-9.
17. 17 Border WA, Noble NA. Transforming growth factor β in tissue fibrosis, N Engl J Med 1994; 331:1286-92.
18. 18 Border WA, Okuda S, Languino LR, Ruoslathi E. Transforming growth factor-β regulates production of proteoglycans by mesangial cells. Kidney Int 1990; 37:689-95.
19. 19 Gesualdo L, Di Paolo S, Ranieri E, Schena FP. Trapidil inhibits human mesangial cell proliferation: effect on PDGF β-receptor binding and expression. Kidney Int 1994; 46:1002-9.
20. 20 Chomezynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162:156-9.
21. 21 Di Paolo S, Gesualdo L, Ranieri E, Grandaliano G, Schena FP. High glucose concentration induces the overexpression of transforming growth factor-β through the activation of a platelet-derived growth factor loop in human mesangial cells. Am J Pathol 1996; 149:2095-106.
22. 1 and its receptor by cyclosporine in human T lymphocytes. Transplantation 1995; 60:718-23.
23. 23 Belitsky P, Ghose T, Givner M, Rowden G, Pope B. Tissue distribution of cyclosporine A in the mouse: a clue to toxicity? Clin Nephrol 1986; 25 (Suppl. 1):S27-S29.
24. 24 Lemaire M, Fahr A, Maurer G. Pharmacokinetics of cyclosporine: inter-and intra-individual variations and metabolic pathways. Transplant Proc 1990; 22:1110-2.
25. 25 Perico N, Deteheva A, Khalil EI, Remuzzi G. Cyclosporine induces glomerulosclerosis: three-dimensional definition of the lesions in a rat model of renal transplant. Kidney Int 1996; 49:1283-8.
26. 26 Li B, Sehajpal PK, Khanna A et al. Differential regulation of transforming growth factor β and interleukin 2 genes in human T cells: demonstration by usage of novel competitor DNA constructs in the quantitative polymerase chain reaction. J Exp Med 1991; 174: 1259-62.
27. 1, in experimental chronic cyclosporine nephropathy. Kidney Int 1996; 49:1141-51.
28. 28 Kim BA, Kang SA, Cho YJ et al. Effects of low density lipoprotein on type IV collagen production by cultured rat mesangial cells. Nephron 1994; 67:327-33.
29. 29 Rovin II, Tan LC. LDL stimulates mesangial fibronectin production and chemoattractant expression. Kidney Int 1993; 43:218-25.
30. 30 Studer RK, Craven PA, De Rubertis FR. Low-density lipoprotein stimulation of mesangial cell fibronectin synthesis: role of protein kinase C and transforming growth factor-β. J Lab Clin Med 1995; 125:86-95.
31. 31 Ding G, Van Goor H, Ricardo SD, Orlowski JM, Diamond JR. Oxidized LDL stimulates the expression of TCF-β and fibronectin in human glomerular epithelial cells. Kidney Int 1997; 51:147-54.
32. 32 Duymelinck C, Dauwe SEH, Nouwen EJ, De Broe ME, Verpooten GA. Cholesterol feeding accentuates the cyclosporine-induced elevation of renal plasminogen activator inhibitor type I. Kidney Int 1997; 51:1818-30.
33. 33 Van Goor II, Ding G, Kees-Folts D, Grond J, Schreiner GF, Diamond JR. Biology of disease. Macrophages and renal disease. Lab Invest 1994; 71:456-64.
34. 34 Golay J, Cusmano G, Introna M. Independent regulation of c-myc, B-myb, and c-myb gene expression by inducers and inhibitors of proliferation in human B lymphocytes. J Immunol 1992; 149: 300-8.
35. 35 Grone EF, Abboud HE, Hohne M et al. Actions of lipoproteins in cultured human mesangial cells: modulation by mitogenic vasoconstrictors. Am J Physiol 1992; 263:F686-F696.